Allowing post-submission materials.
Find Funding Opportunities
NIH Extramural Response to Natural Disasters and Other Emergencies
In emergency situations, the NIH’s immediate concern is for the health and safety of people and animals in the programs we oversee. Visit the NIH Extramural Response to Natural Disasters and Other Emergencies web page for biomedical research community resources, including NIH Guide Notices and other information of particular relevance to investigators and their institutions, links to web pages listing NIH’s response to certain major events (past and present); and links to similar web sites from other Federal agencies.
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Notice of Change: Post-Submission Materials for RFA-NS-24-005 - BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-042
Thursday, December 14, 2023
Notice Type: NOT
Notice of Information: NINDS will increase the salary allowance for K00 awardees for NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-016
Tuesday, December 5, 2023
Notice Type: NOT
The purpose of this notice is to inform the community that the NIH Blueprint and BRAIN Initiative are changing the funding allowance for K00 awards to RFA-NS-21-012, RFA-NS-19-011, and RFA-NS-18-007.This change will apply to all new and continuing NIH Blueprint and BRAIN Initiative F99/K00 awards.
Currently, the NIH Blueprint and BRAIN Initiative provides up to $58,000 salary during the K00 phase. Effective for new and continuing K00 awards made with FY2024 funds, the NIH Blueprint and BRAIN Initiative will contribute up to $60,000 in the first year toward the salary of the career award recipient. This will be increased to $63,300 for the second year, to $66,600 for the third year, and to $69,900 for a fourth year.
Notice of Change to Receipt Dates for RFA-NS-22-069: "HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-099
Monday, December 4, 2023
Notice Type: NOT
Changing the receipt dates
Notice of Change to Key Dates for RFA-NS-24-023: HEAL INITIATIVE: Development and validation of remote or patient wearable device derived objective biosignatures or functional assessments to monitor pain for use as endpoints in clinical trials (UG3/UH3)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-029
Monday, December 4, 2023
Notice Type: NOT
Adding a receipt date.
Notice of Change: Extension of PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)" by one Council Round
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-020
Thursday, November 30, 2023
Notice Type: NOT
The purpose of this notice is to inform applicants of an extension to PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)". The NOFO will be extended by one additional council round.
Notice of Change: Extension of PAR-22-028 "Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)" by one Council Round
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-035
Thursday, November 30, 2023
Notice Type: NOT
The purpose of this notice is to inform applicants of an extension to PAR-22-028 "Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)". The NOFO will be extended by one additional council round.
Notice of Change: Extension of PAR-21-224 "NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-037
Thursday, November 30, 2023
Notice Type: NOT
The purpose of this notice is to inform applicants of an extension to PAR-21-224 "NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)". This notice of funding opportunity (NOFO) is being extended by one additional council round.
Technical Assistance Webinars for RFA-NS-24-029 Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-036
Monday, November 27, 2023
Notice Type: NOT
The purpose of this notice is to inform applicants of an informational webinar for RFA-NS-24-029 Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)".
Notice of Change to IC-specific Information for the NINDS for PAR-22-105 and PAR-22-109 Dissemination and Implementation Research in Health NOFOs
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-032
Wednesday, November 22, 2023
Notice Type: NOT
The purpose of this notice is to inform applications of NINDS' IC-specific information for PAR-22-105 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) and PAR-22-109 Dissemination and Implementation Research in Health (R21 Clinical Trial Optional).
Notice of Change to IC-specific Information for the NINDS for PAR-22-106 Dissemination and Implementation Research in Health NOFO
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-034
Monday, November 20, 2023
Notice Type: NOT
The purpose of this notice is to inform applications of NINDS' IC-specific information for PAR-22-106 Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed).